B Vitamins Can Reduce Schizophrenia Symptoms

afd706fd-5b6a-4cf0-90a4-677f691893a7articleimage.jpg

16 Feb 2017 --- A review of worldwide studies has found that add-on treatment with high-dose b-vitamins - including B6, B8 and B12 - can significantly reduce symptoms of schizophrenia more than standard treatments alone.

The research looking into the effect of vitamin and mineral supplements on symptoms of schizophrenia was funded by The Medical Research Council and University of Manchester, and is published in Psychological Medicine, one of the world’s leading Psychology journals.

Lead author Joseph Firth, based at the University’s Division of Psychology and Mental Health, said, “Looking at all of the data from clinical trials of vitamin and mineral supplements for schizophrenia to date, we can see that B vitamins effectively improve outcomes for some patients.

“This could be an important advance, given that new treatments for this condition are so desperately needed.”

Schizophrenia affects around 1% of the population and is among the most disabling and costly long term conditions worldwide.

Currently, treatment is based around the administration of antipsychotic drugs.

Although patients typically experience remission of symptoms such as hallucinations and delusions within the first few months of treatment, long-term outcomes are poor; 80% of patients relapse within five years.

The researchers reviewed all randomized clinical trials reporting effects of vitamin or mineral supplements on psychiatric symptoms in people with schizophrenia.

In what is the first meta-analysis carried out on this topic, they identified 18 clinical trials with a combined total of 832 patients receiving antipsychotic treatment for schizophrenia.

B-vitamin interventions which used higher dosages or combined several vitamins were consistently effective for reducing psychiatric symptoms, whereas those which used lower doses were ineffective.

Also, the available evidence also suggests that B-vitamin supplements may be most beneficial when implemented early on, as b-vitamins were most likely to reduce symptoms when used in studies of patients with shorter illness durations.

Firth added, “High-dose B-vitamins may be useful for reducing residual symptoms in people with schizophrenia, although there were significant differences among the findings of the studies we looked at.”

“There is also some indication that these overall effects may be driven by larger benefits among subgroups of patients who have relevant genetic or dietary nutritional deficiencies.”

Co-author Jerome Sarris, Professor of Integrative Mental Health at Western Sydney University, added: “This builds on existing evidence of other food-derived supplements, such as certain amino-acids, been beneficial for people with schizophrenia.”

“These new findings also fit with our latest research examining how multi-nutrient treatments can reduce depression and other disorders.”

The research team says more studies are now needed to discover how nutrients act on the brain to improve mental health, and to measure effects of nutrient-based treatments on other outcomes such as brain functioning and metabolic health.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Bone and joint health: Consumer demands and promising ingredients

19 Apr 2018 --- Mobility, which incorporates bone and joint health, is becoming a key concern for a range of demographics. NutritionInsight spoke with a number of key suppliers in the bone and joint health space about the key ingredients to look out for, as well as some key consumer demands driving innovation in this space.

Nutrition & Health News

New study sheds light on non-celiac gluten avoidance

18 Apr 2018 --- People who avoid gluten in their diets, often avoid other food types – such as dairy and eggs – and are more likely to experience frequent adverse physiological symptoms after food consumption. The research sought to uncover why the popularity of gluten-free diets has risen so much amongst those who do not have medical gluten sensitivities.

Nutrition & Health News

Probiotic peanut allergy treatment: Chr. Hansen enters new partnership

18 Apr 2018 --- Probiotic strain, LGG, can potentially play a part in peanut allergy treatment. Prota Therapeutics, developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen, Danish food ingredients producer, to assess LGG in a clinical trial to develop a treatment for the allergy. Chr. Hansen tells NutritionInsight that the partnership is in effect as from today, and strengthens the position of Chr. Hansen in a market expected to grow to €10billion by 2025.

Nutrition & Health News

“New superfood”: Alfalfa ingredient steps up on sustainability

17 Apr 2018 --- Luzixeen, developed by L-RD (Luzerne (Alfalfa – Research & Development) have integrated an innovative technical approach to their biorefinery process, which enables the entire alfalfa crop to be used. The process of valirsation makes it possible to take advantage of the total plant, which is local to France. Luzixeen is based on sustainable farming of the local alfalfa, and they tout the environmental benefits of the eco-compatible culture which they also hail as a “new superfood.”

Nutrition & Health News

US FDA moves to ban bulk sale of concentrated caffeine products to consumers 

16 April 2018 --- The US Food and Drug Administration (FDA) has issued guidance declaring that dietary supplements containing pure or highly concentrated caffeine, in powder or liquid forms, are unlawful when sold in bulk quantities directly to consumers. The agency notes that it is prepared to take immediate steps to begin removing such “dangerous bulk products.”

More Articles
URL : http://www.nutritioninsight.com:80/news/B-Vitamins-Can-Reduce-Schizophrenia-Symptoms.html?type=article